TADDEUCCI, PAOLO
 Distribuzione geografica
Continente #
NA - Nord America 118
EU - Europa 49
AS - Asia 8
Totale 175
Nazione #
US - Stati Uniti d'America 118
IT - Italia 16
DE - Germania 15
IE - Irlanda 11
CN - Cina 4
FR - Francia 3
VN - Vietnam 3
SE - Svezia 2
GR - Grecia 1
IN - India 1
RU - Federazione Russa 1
Totale 175
Città #
Buffalo 15
Ann Arbor 13
Fairfield 13
Dublin 11
Siena 10
Ashburn 9
Cambridge 9
Houston 9
Seattle 8
Santa Cruz 6
Wilmington 6
Woodbridge 6
Dong Ket 3
San Diego 2
Shanghai 2
Stockholm 2
Wuhan 2
Bengaluru 1
Castelcovati 1
Columbus 1
Florence 1
Lake Forest 1
Las Vegas 1
Los Angeles 1
New York 1
Provo 1
San Francisco 1
University Park 1
Yellow Springs 1
Totale 138
Nome #
Searching Novel Therapeutic Targets for Scleroderma: P2X7-Receptor Is Up-regulated and Promotes a Fibrogenic Phenotype in Systemic Sclerosis Fibroblasts, file e0feeaa6-56fd-44d2-e053-6605fe0a8db0 165
Gorlin Goltz Syndrome: Beware of Melanoma, file a2b01ab2-a75f-4d88-8eb9-0fd0ee092d64 10
A case of chronic spontaneous urticaria unresponsive to ligelizumab successfully treated with omalizumab, file 7bcafa65-8297-4e40-9829-8370fb66818f 1
Efficacy of Dupilumab in two patients with severe and recalcitrant atopic dermatitis previously treated with extracorporeal photopheresis, file e0feeaa9-0c6c-44d2-e053-6605fe0a8db0 1
null, file e0feeaa9-1e60-44d2-e053-6605fe0a8db0 1
Long-term efficacy of a Vismodegib regime including a 1-week drug holiday every month in two patients with Gorlin Goltz syndrome, file e1f50169-4f69-40ac-84fa-7403ecd63aac 1
Totale 179
Categoria #
all - tutte 545
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 545


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201916 0 0 0 0 0 0 0 0 0 0 7 9
2019/202046 14 6 3 3 1 4 2 3 5 2 1 2
2020/202136 3 2 1 3 1 1 1 2 0 12 4 6
2021/202225 0 3 1 0 2 1 3 0 1 2 9 3
2022/202322 1 1 6 4 0 4 1 0 0 1 4 0
2023/202418 0 0 1 3 0 6 6 0 0 1 1 0
Totale 179